Literature DB >> 11666958

Stereoselective Synthesis of HIV-1 Protease Inhibitor, DMP 323.

Michael E. Pierce1, Gregory D. Harris, Qamrul Islam, Lilian A. Radesca, Louis Storace, Robert E. Waltermire, Ed Wat, Prabhakar K. Jadhav, George C. Emmett.   

Abstract

DMP 323, a potent HIV-1 protease inhibitor, has been synthesized by an efficient stereoselective process, amenable to large scale preparations. The core C(2) symmetric diol was synthesized by a stereoselective pinacol coupling of CBZ protected D-phenylalanine. Judicious selection of protecting groups allowed cyclic urea formation under mild conditions, enhanced the ease of bis-alkylation, and led to intermediates which were easily purified without chromatography. Additionally, a one-pot, high yield process was developed to prepare the alkylating agent, 4-[(triphenylmethoxy)methyl]benzyl chloride from 1,4-benzenedimethanol.

Entities:  

Year:  1996        PMID: 11666958     DOI: 10.1021/jo951847u

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  1 in total

1.  2,5-Anhydro sugar diacid and 2,5-anhydro sugar diamine based C 2 symmetric peptidomimetics as potential HIV-1 protease inhibitors.

Authors:  T K Chakraborty; Subhash Ghosh; M H V Ramana Rao; A C Kunwar; H Cho; A K Ghosh
Journal:  Tetrahedron Lett       Date:  2000-12-08       Impact factor: 2.415

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.